NAUT
HEALTHCARENautilus Biotechnology Inc
$2.94+0.08 (+2.80%)PRE
Live · NASDAQ · May 8, Close
AI Insight
What's Moving NAUT Today?
No stock-specific AI insight has been generated for NAUT yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.62$4.31
$2.94
Fundamentals
Market Cap$374M
P/E Ratio—
EPS$-0.46
Dividend Yield—
Dividend / Share—
ROE-0.3%
Profit Margin—
Debt / Equity—
Trading
Volume242K
Avg Volume (10D)—
Shares Outstanding127.1M
NAUT News
20 articles- 3 Promising Penny Stocks With Market Caps Up To $900MYahoo Finance·May 5, 2026
- Nautilus Biotechnology (NASDAQ:NAUT) Is In A Good Position To Deliver On Growth PlansYahoo Finance·May 5, 2026
- Nautilus Biotechnology Inc (NAUT) Q1 2026 Earnings Call Highlights: Strategic Advances Amid ...Yahoo Finance·Apr 29, 2026
- Nautilus Biotechnology Q1 Earnings Call HighlightsMarketbeat·Apr 28, 2026
- Nautilus Biotechnology Reports First Quarter 2026 Financial ResultsYahoo Finance·Apr 28, 2026
- Here is Why Nautilus Biotechnology (NAUT) is One of the Best Life Sciences Penny Stocks to BuyYahoo Finance·Apr 14, 2026
- Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026Yahoo Finance·Apr 9, 2026
- Q1 Virtual Investor Summit Presentations Now Available On DemandYahoo Finance·Mar 26, 2026
- Nautilus Biotechnology Unveils Voyager Proteomics Platform, Targets Beta Access in 2H and Launch Next YearMarketbeat·Mar 25, 2026
- Nautilus Biotechnology And 2 Other Compelling Penny Stocks For Your WatchlistYahoo Finance·Mar 25, 2026
- Nautilus Biotechnology to Participate in the Investor Summit Group Virtual ConferenceYahoo Finance·Mar 24, 2026
- Investor Summit Announces Q1 Presenter Line Up (Presentations 3/25, 1-on-1s 3/26)Yahoo Finance·Mar 20, 2026
- Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager PlatformYahoo Finance·Mar 18, 2026
- Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of SalesYahoo Finance·Mar 2, 2026
- Nautilus Biotechnology, Inc. Q4 2025 Earnings Call SummaryMoby·Feb 27, 2026
- Nautilus Biotechnology Q4 Earnings Call HighlightsMarketbeat·Feb 26, 2026
- Nautilus Biotechnology Inc (NAUT) Q4 2025 Earnings Call Highlights: Strategic Advances and ...Yahoo Finance·Feb 26, 2026
- Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial ResultsYahoo Finance·Feb 26, 2026
- Nautilus Biotechnology Unveils Voyager Platform, Enabling Single-Molecule Iterative Mapping, at US HUPO 2026Yahoo Finance·Feb 24, 2026
- Jefferies Upgrades BETA Technologies, Inc. (BETA) to BuyYahoo Finance·Feb 22, 2026
All 20 articles loaded
Price Data
Open$0.00
Previous Close$2.86
Day High$0.00
Day Low$0.00
52 Week High$4.31
52 Week Low$0.62
52-Week Range
$0.62$4.31
$2.94
Fundamentals
Market Cap$374M
P/E Ratio—
EPS$-0.46
Dividend Yield—
Dividend / Share—
ROE-0.3%
Profit Margin—
Debt / Equity—
Trading
Volume242K
Avg Volume (10D)—
Shares Outstanding127.1M
About Nautilus Biotechnology Inc
Nautilus Biotechnology, Inc., a development-stage life sciences company, is dedicated to creating platform technology to quantify and unlock proteome complexity. The company is headquartered in Seattle, Washington.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—